Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses | Patent Application Number 17005734

17005734
Not Appealed
Patent Number-
Publication NumberUS 20200392242 A1
Filled DateAug 28, 2020
Priority DateApr 19, 2019
Inventor/ApplicantsXiangyang Liu
Jordan Schecter
ExaminesALSOMAIRY, SARAH ABDOALATIF
Art Unit1642
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.